Their further study showed that NASH can impair the effects of M3-RNA vaccine and anti-OX40 antibody treatment against mouse liver tumors induced by intrahepatic injections of B16 melanoma and CT26 colon cancer cells [105]. The gene discussed is TNFRSF4; the disease is metabolic dysfunction-associated steatohepatitis.